In terms of the immune response, A1 dysfunction has profound effects on the immune response [72,73,74] and other SNVs (e.g., hypoxanthine-guanine phosphoribosyl transferase (HPRT)) have been shown to alter the immunity of MS patients [75,76,77,78]. Here, HPRT1 is linked to myeloid sarcoma.